Learn more about whether Tandem Diabetes Care, Inc. is a good stock to buy or sell based on recent news as well as its key financial metrics. Read on to find out how (TNDM) grades on certain ...

Tandem Diabetes Care ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3. Tandem Diabetes Care ...

Bullish Analyst Says RBC Capital Markets initiates coverage on Tandem Diabetes Care (TNDM) with an Outperform rating and $65 price target, citing growth opportunities in the U.S. Type 1 and Type 2 ...

We recently compiled a list of the 10 Oversold Healthcare Stocks To Invest In. In this article, we are going to take a look ...

Fintel reports that on December 2, 2024, Morgan Stanley upgraded their outlook for Tandem Diabetes Care (NasdaqGM:TNDM) from ...

In the last three months, 5 analysts have published ratings on Tandem Diabetes Care (NASDAQ:TNDM), offering a diverse range of perspectives from bullish to bearish. The table below provides a ...

Sales: In the United States, GAAP sales included $1.0 million incremental sales relating to Tandem Choice compared to a sales deferral of $8.2 million. Non-GAAP sales exclude Tandem Choice-related ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that ...